Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
America's Car-Mart Reports First Quarter Fiscal Year 2026 Results
-
America's Car-Mart Reports First Quarter Fiscal Year 2026 Results
-
Currency Exchange International to Report its Third Quarter 2025 Results on September 10, 2025, and Host Earnings Conference Call on September 11, 2025 at 8:30 AM EST
-
American Tungsten Progresses its IMA Mine Rehabilitation
-
Robex Announces Voting Results for 2025 Annual General and Special Meeting of Shareholders
-
Abaxx Launches Adaptive Infrastructure as a Cross-Market Custodian for Environmental Markets and Digital Title Assets
-
Dynacor Provides Corporate Update Including Expansion Progress
-
CorVista Health Announces Publication of Real-World Case Series in the Journal of the American College of Cardiology Exploring its Non-Invasive Test for Earlier Diagnosis of Pulmonary Hypertension
-
TG Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
-
Digi Power X, Via Wholly-Owned Subsidiary US Data Centers Inc., Awarded Tier 3 ANSI/TIA-942-C “TIA-942 Ready” Certification for ARMS 200 AI Modular Platform
-
Zevra Therapeutics Presents Positive New Data Supporting Foundational Role of MIPLYFFA® (arimoclomol) for the Treatment of Niemann-Pick Disease Type C at the International Congress of Inborn Errors o
-
RARE AND SOUGHT-AFTER BOURBONS MAKE THEIR DEBUT AT THE ART OF BOURBON SEPTEMBER 18
-
Nuvectis Pharma to Participate at the H.C. Wainwright 27th Annual Global Investment Conference
-
AeroChamber2Go® Valved Holding Chamber Now Available at Walmart Pharmacy: A Game-Changer for On-the-Go Inhaler Users
-
Dragonfly Energy Secures Patent for Wakespeed® Charge Control Technology
-
PyroGenesis’ Latest Fumed Silica Test Results Post 3X Increase in Material Surface Area
-
A Race Against Blindness Awards Additional $1 Million Grant to Advance Clinical Trial for Sight-Saving Gene Therapy for Bardet-Biedl Syndrome 1 (BBS1)
-
Pluristyx and BioLamina Announce Strategic Partnership to Accelerate Development of Stem Cell-Based Therapies
-
SAIC Announces Second Quarter of Fiscal Year 2026 Results
-
Stabilization Notice: Pre Stab Notice - Dometic Group AB
-
Fury Intercepts 59 Metres of 1.59 g/t Gold and 1.5 Metres of 546 g/t Silver at the Sakami Gold Project in Quebec
-
Brady Corporation Reports Record Adjusted EPS in its Fiscal 2025 Fourth Quarter and Announces its Fiscal 2026 EPS Guidance
-
Mobix Labs Secures AI Drone Contract and Expands into Multi-Billion- Dollar Infrastructure Market
-
SPEAR Study Group to Present its Recommended Long COVID Antibody Study Design Featuring Invivyd’s VYD2311 At RECOVER-TLC Workshop September 9-10, 2025
-
The School Privacy Report Releases Back-to-School Emergency Edition
-
Koryx Announces Updated PEA Results for the Haib Copper Project, Southern Namibia
-
Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference
-
HPQ Achieves Pilot-Scale Milestone in Commercial Fumed Silica Production, Sets Sights on Higher-Value Market Segment
-
Brunswick Exploration Starts Maiden Drilling Program at Anatacau Main
-
Q2 Metals Increases Drill Activity and Provides Exploration Update on the Cisco Lithium Project in Quebec, Canada
-
Puro.earth Secures €11 M Series B Financing Led by Nasdaq with Participation from Fortum Innovation & Venturing to strengthen its supplier infrastructure
-
Algernon Pharmaceuticals Announces Name Change to Algernon Health
-
Brooge Energy Limited Sets Updated Record Date – Holders must contact brokers to register shares with Continental Stock Transfer & Trust if they are outside the United States and Not U.S. Person
-
Join XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10
-
Churchill Resources to Commence Fall Drilling & Trenching Program at the Past-Producing Frost Cove Antimony Mine
-
Neuphoria Therapeutics Completes Target Enrollment in Phase 3 AFFIRM-1 Trial of BNC-210 in Social Anxiety Disorder (SAD)
-
BPGbio Announces Completion of Enrollment for Phase 2b Trial of BPM31510 for Glioblastoma (GBM)
-
RetailPro, a Nayax Company, and Onebeat Partner to Transform Inventory from Static Data to Real-Time Profit Engine
-
Agios Provides Update on U.S. PDUFA Goal Date for PYRUKYND® (mitapivat) in Thalassemia
-
Skye’s CB1 Inhibitor, Nimacimab, Demonstrates Superior Weight Loss and Differentiated Mechanisms from Monlunabant, and Continues to Show Enhanced Combination with Tirzepatide with Durable Post-Trea
-
TappAlpha Expands ETF Lineup with the Innovation 100 Growth & Daily Income ETF (TDAQ)
-
Nusano Announces September Conference Schedule
-
BioXcel Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
-
Hinge Bio Expands Leadership Team to Drive Clinical Development of GEM-DIMER™ Programs and Announces Publication in Scientific Reports
-
Merakris Therapeutics Enrolls 30th Subject in Expanded Access Program of MTX-001; Highlights Clinical Progress at SAWC Fall 2025
-
Sol-Gel Announces Health Canada Approval of EPSOLAY®
-
Purple Biotech Announces New Data Supporting the Unique Design of CAPTN-3 Tri-Specific Antibody IM1240 in Collaboration with the Icahn School of Medicine at Mount Sinai
-
Brooge Energy Limited Sets Updated Record Date – Holders must contact brokers to register shares with Continental Stock Transfer & Trust if they are outside the United States and Not U.S. Persons
-
GT Biopharma to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
-
Puro.earth Secures €11 M Series B Financing Led by Nasdaq with Participation from Fortum Innovation & Venturing to strengthen its supplier infrastructure
